Elizabeth J Brisbois Selected Research

S-Nitroso-N-Acetylpenicillamine

11/2021	Reduction in Foreign Body Response and Improved Antimicrobial Efficacy via Silicone-Oil-Infused Nitric-Oxide-Releasing Medical-Grade Cannulas.
9/2019	Multifunctional S-Nitroso-N-acetylpenicillamine-Incorporated Medical-Grade Polymer with Selenium Interface for Biomedical Applications.
3/2017	Reduction of Thrombosis and Bacterial Infection via Controlled Nitric Oxide (NO) Release from S-Nitroso-N-acetylpenicillamine (SNAP) Impregnated CarboSil Intravascular Catheters.
1/2015	Reduction in Thrombosis and Bacterial Adhesion with 7 Day Implantation of S-Nitroso-N-acetylpenicillamine (SNAP)-Doped Elast-eon E2As Catheters in Sheep.
11/2013	The mediation of platelet quiescence by NO-releasing polymers via cGMP-induced serine 239 phosphorylation of vasodilator-stimulated phosphoprotein.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elizabeth J Brisbois Research Topics

Disease

15	Infections 07/2022 - 01/2015
14	Thrombosis (Thrombus) 05/2020 - 11/2013
7	Bacterial Infections (Bacterial Infection) 10/2021 - 10/2014
3	Inflammation (Inflammations) 01/2022 - 12/2019
3	Sepsis (Septicemia) 01/2022 - 10/2015
3	Wounds and Injuries (Trauma) 01/2022 - 10/2014
2	Catheter-Related Infections 01/2022 - 06/2021
1	Dental Caries (Decay, Dental) 05/2022
1	Foreign Bodies (Foreign Body) 11/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2021
1	Coinfection 03/2021
1	Thrombocytopenia (Thrombopenia) 05/2020
1	Hemorrhage 05/2020
1	Pulmonary Hypertension 01/2020
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2019
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2019
1	Ventilator-Associated Pneumonia 01/2019
1	Cicatrix (Scar) 10/2014
1	Burns 10/2014

Drug/Important Bio-Agent (IBA)

15	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2022 - 10/2014
9	PolymersIBA 07/2022 - 11/2013
5	SolutionsIBA 01/2022 - 10/2016
5	S-Nitroso-N-AcetylpenicillamineIBA 11/2021 - 11/2013
2	SiliconesIBA 07/2022 - 01/2022
2	Therapeutic UsesIBA 01/2022 - 10/2021
2	Biocompatible Materials (Biomaterials)IBA 01/2022 - 09/2019
2	GasotransmittersIBA 10/2021 - 09/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 03/2021 - 01/2019
1	FluoridesIBA 05/2022
1	HydrogelsIBA 05/2022
1	Poloxamer (Poloxamer 407)IBA 05/2022
1	ChlorhexidineIBA 01/2022
1	SolventsIBA 11/2021
1	Silicone Elastomers (SE 30)IBA 11/2021
1	Silicone OilsIBA 11/2021
1	S-NitrosothiolsIBA 10/2021
1	Antiviral Agents (Antivirals)IBA 10/2021
1	Acetylcysteine (Siran)FDA LinkGeneric 06/2021
1	EstersIBA 06/2021
1	AnticoagulantsIBA 05/2020
1	Heparin (Liquaemin)FDA LinkGeneric 05/2020
1	Insulin (Novolin)FDA Link 12/2019
1	Polyvinyl Chloride (PVC)IBA 10/2019
1	SeleniumIBA 09/2019
1	Pharmaceutical PreparationsIBA 05/2017
1	A 7 (A-7)IBA 10/2015
1	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2014
1	argatroban (MPQA)FDA Link 08/2014

Therapy/Procedure

8	Catheters 01/2022 - 01/2015
4	Therapeutics 01/2022 - 05/2017
2	Central Venous Catheters 06/2021 - 10/2016
1	Oral Hygiene (Dental Hygiene) 05/2022
1	Indwelling Catheters (Indwelling Catheter) 06/2021
1	Infusion Pumps (Infusion Pump) 12/2019
1	Cannula 12/2019
1	Extracorporeal Circulation 01/2016